Abstract
Overeating and associated obesity are major public health problems. In addition to its notable adverse health consequences, the behavior of overeating has significant neurobiological and psychological underpinnings. Current classification systems of mental disorders (DSM-IV and ICD-10) address this increasingly prevalent “disorder” in a limited and inconsistent manner. Several similarities between overeating and substance dependence have been documented with regards to phenomenology, shared neurobiology, and treatment. This has led to suggestions that a new category of “food addiction” be added to our psychiatric nosology and that this category be included with substance use disorders under a broad rubric of “addiction disorders”. In this article, we consider the rationale for this recommendation and evaluate its pros and cons. We summarize how the problem of overeating is addressed in our current classification systems and discuss DSM-5 approaches to the issue.
Keywords: Binge-eating, obesity, addiction, DSM, psychiatric classification, commonalities, nosological, psychoanalytic, impulse, syndrome, anorexia, gambling, bulimia, DISORDER
Current Pharmaceutical Design
Title: Should Overeating and Obesity be Classified as an Addictive Disorder in DSM-5?
Volume: 17 Issue: 12
Author(s): Claudia Moreno and Rajiv Tandon
Affiliation:
Keywords: Binge-eating, obesity, addiction, DSM, psychiatric classification, commonalities, nosological, psychoanalytic, impulse, syndrome, anorexia, gambling, bulimia, DISORDER
Abstract: Overeating and associated obesity are major public health problems. In addition to its notable adverse health consequences, the behavior of overeating has significant neurobiological and psychological underpinnings. Current classification systems of mental disorders (DSM-IV and ICD-10) address this increasingly prevalent “disorder” in a limited and inconsistent manner. Several similarities between overeating and substance dependence have been documented with regards to phenomenology, shared neurobiology, and treatment. This has led to suggestions that a new category of “food addiction” be added to our psychiatric nosology and that this category be included with substance use disorders under a broad rubric of “addiction disorders”. In this article, we consider the rationale for this recommendation and evaluate its pros and cons. We summarize how the problem of overeating is addressed in our current classification systems and discuss DSM-5 approaches to the issue.
Export Options
About this article
Cite this article as:
Moreno Claudia and Tandon Rajiv, Should Overeating and Obesity be Classified as an Addictive Disorder in DSM-5?, Current Pharmaceutical Design 2011; 17 (12) . https://dx.doi.org/10.2174/138161211795656701
DOI https://dx.doi.org/10.2174/138161211795656701 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Physiological Relevance of Protein Phosphatase 1 and its Interacting Proteins to Health and Disease
Current Medicinal Chemistry Insulin Neuritis and Diabetic Cachectic Neuropathy: A Review
Current Diabetes Reviews Interplay between Catalysts and Substrates for Activity of Class Ib Aminoacyl-tRNA Synthetases and Implications for Pharmacology
Current Topics in Medicinal Chemistry The Radiosensitizing Effect of Olanzapine as an Antipsychotic Medication on Glioblastoma Cell
Current Radiopharmaceuticals Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets The Synthetic and Biological Attributes of Pyrazole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry Autoimmunity in Alzheimers Disease as Evidenced by Plasma Immunoreactivity Against RAGE and Aβ42: Complication of Diabetes
Current Alzheimer Research A Comprehensive Review on Exosomes and Microvesicles as Epigenetic Factors
Current Stem Cell Research & Therapy An Experimental Model for Exudative Age-related Macular Degeneration with Choroidal Neovascularization Using the Common Marmoset
Current Neurovascular Research Cellular and Molecular Mechanisms Involved in the Action of Vitamin D Analogs Targeting Vitiligo Depigmentation
Current Drug Targets The Targets of Curcumin
Current Drug Targets Determination of Mutation Pattern in Human Androgen Receptor by Means of Amino-Acid Pair Predictability
Protein & Peptide Letters Editorial
Recent Patents on CNS Drug Discovery (Discontinued) Conformational Changes and Aggregation of Expanded Polyglutamine Proteins as Therapeutic Targets of the Polyglutamine Diseases: Exposed β-Sheet Hypothesis
Current Pharmaceutical Design Proteomic Analysis of Endothelin-1 Targets in the Regulation of Cardiomyocyte Proliferation
Current Topics in Medicinal Chemistry Retinal Ganglion Cell Gene Therapy and Visual System Repair
Current Gene Therapy Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer's Disease
Current Computer-Aided Drug Design DeepSSPred: A Deep Learning Based Sulfenylation Site Predictor Via a Novel nSegmented Optimize Federated Feature Encoder
Protein & Peptide Letters Tumour Necrosis Factor α Gene Promoter and its Role in Rheumatoid Arthritis Outcome and Pharmacogenetics
Current Pharmacogenomics Phosphodiesterase Type 5 Inhibitors: Unmet Needs
Current Pharmaceutical Design